Cybernet Data Systems Inc.
Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, has announced business highlights and certain preliminary financial results for the first quarter ended March 31, 2023. The company has appointed John R. Sylvester as Chairman of the Board, and Gerard
Cybernet Data Systems Inc.
Acadia Pharmaceuticals Inc. announced its financial results for the first quarter of 2023, showcasing strong growth in NUPLAZID sales and a decrease in research and development expenses. The Company's net loss for the quarter decreased to $43.0 million, or $0.27 per common share, compared to a
United States. Food and Drug Administration
Democratic Rep. Alexandria Ocasio-Cortez and other lawmakers have called on the Biden administration to ignore a federal judge's ruling in Texas suspending the approval of mifepristone, a common abortion pill. The ruling, issued by a Trump-appointed judge, has been met with criticism from Democrats, who argue that the
United States. Food and Drug Administration
Dozens of pharmaceutical executives, including top leaders from Pfizer, Novartis, Biogen, and Merck, have signed a letter criticizing a recent US judicial ruling that could block access to the widely used abortion pill mifepristone. The ruling, issued by Texas federal judge Matthew Kacsmaryk, has been condemned as an attack on
Vaccines
Guyana has announced that it will accept travelers vaccinated with select vaccines not yet approved by international health bodies, including the US FDA and the WHO. The move comes as the country seeks to facilitate travel while maintaining health and safety protocols for its citizens. Currently, vaccines approved by the
Vaccines
The Centers for Disease Control and Prevention (CDC) has endorsed the use of Moderna and Johnson and Johnson COVID-19 booster shots following a recommendation from the Advisory Committee on Immunization Practices' (ACIP). The endorsement follows the Food and Drug Administration's (FDA) October 20 announcement approving the emergency
Vaccines
Stocks rose modestly on Tuesday after the Food and Drug Administration gave full approval for Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine, with investors awaiting the Jackson Hole symposium later in the week for hints on future Federal Reserve policy. A rebound in Chinese technology stocks also boosted
Pfizer Inc.
As the US Food and Drug Administration (FDA) grants full approval to Pfizer's COVID-19 vaccine, employers are swiftly moving to require workers to get vaccinated, citing the need to protect employees, customers, and the wider community. The FDA's decision, made public on Monday, has removed a
Pfizer Inc.
As the full US authorisation of the Pfizer coronavirus vaccine drew near, the federal Food and Drug Administration (FDA) took a firm stance against the use of ivermectin, a medicine used to deworm livestock, for COVID-19 treatment. The agency's simple yet emphatic message to Americans was: "You
Vaccines
U.S. Senator Roger Marshall, M.D. has sent a letter to President Joe Biden calling on him to make all seniors eligible for COVID-19 vaccine booster shots immediately. This urgent request comes as the delta variant is surging across the country, putting seniors and those at high risk at
Cybernet Data Systems Inc.
Philip Morris International Inc. (PMI) has announced a tender offer to acquire the inhaled therapeutics company Vectura Group plc. The proposed acquisition is part of PMI's long-term strategy to transform its business and leverage its capabilities to develop inhaled therapeutics. Vectura is a provider of innovative inhaled drug
Cybernet Data Systems Inc.
Ligand Pharmaceuticals Incorporated's partner, Travere Therapeutics, Inc., announced positive topline interim results from the ongoing pivotal Phase 3 PROTECT Study of sparsentan, an investigational product candidate for the treatment of IgA nephropathy. The study met its pre-specified interim primary efficacy endpoint with statistical significance, demonstrating a greater than
